{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:41:46Z","timestamp":1776858106124,"version":"3.51.2"},"reference-count":41,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"The Himalaya Drug Company"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern J of Cosmetic Sci"],"published-print":{"date-parts":[[2014,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Yashada bhasma (<jats:styled-content style=\"fixed-case\">YB<\/jats:styled-content>) and <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>ankana (<jats:styled-content style=\"fixed-case\">TA<\/jats:styled-content>) are well characterized minerals used in traditional medicine for the treatment of various skin ailments. Yashada bhasma and <jats:styled-content style=\"fixed-case\">TA<\/jats:styled-content> are a unique preparation of zinc and borax, respectively. The study was conducted to evaluate the <jats:italic>in vitro<\/jats:italic> inhibitory effect of <jats:styled-content style=\"fixed-case\">YB<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> TA<\/jats:styled-content> and its combination (<jats:styled-content style=\"fixed-case\">YBTA<\/jats:styled-content>) on <jats:italic><jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>ropionibacterium acne<\/jats:italic> growth and <jats:italic><jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>.\u00a0acne<\/jats:italic>\u2010induced inflammation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The minerals were tested for anti\u2010<jats:italic><jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>.\u00a0acne<\/jats:italic> activity by disc diffusion and broth microdilution methods. The effect of these minerals on <jats:italic><jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>.\u00a0acne<\/jats:italic> induced <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>\u2010<jats:italic>\u03b1<\/jats:italic> and <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20108 production and gene expression were studied in <jats:styled-content style=\"fixed-case\">THP<\/jats:styled-content>\u20101 cells. <jats:italic>In vitro<\/jats:italic> toxicity was tested on human keratinocytes (<jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>a<jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>a<jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>) and mouse embryonic fibroblasts (<jats:styled-content style=\"fixed-case\">NIH<\/jats:styled-content>3T3) using <jats:styled-content style=\"fixed-case\">MTT<\/jats:styled-content> assay.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The minimum inhibitory concentrations (<jats:styled-content style=\"fixed-case\">MIC<\/jats:styled-content> values) for <jats:styled-content style=\"fixed-case\">YB<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> TA<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">YBTA<\/jats:styled-content> against <jats:italic><jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>.\u00a0acne<\/jats:italic> were 0.1\u00a0\u00b1\u00a00.2, 1.9\u00a0\u00b1\u00a00.5 and 0.3\u00a0\u00b1\u00a00.5\u00a0mg\u00a0mL<jats:sup>\u22121<\/jats:sup>, respectively. <jats:styled-content style=\"fixed-case\">YB<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> TA<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">YBTA<\/jats:styled-content> inhibited <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content><jats:italic>\u03b1<\/jats:italic> by 57.57%, 59.09% and 68.93% and <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20108 production by 48.76%, 47.92% and 51.13% in <jats:italic><jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>.\u00a0acne\u2010<\/jats:italic>stimulated THP\u20101 cells, respectively. The <jats:styled-content style=\"fixed-case\">CTC<\/jats:styled-content><jats:sub>50<\/jats:sub> values on <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>a<jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>a<jats:styled-content style=\"fixed-case\">T<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">NIH3T3<\/jats:styled-content> was 17.44\u00a0\u00b1\u00a00.5 and 16.37\u00a0\u00b1\u00a00.2\u00a0\u03bcg\u00a0mL<jats:sup>\u22121<\/jats:sup> for <jats:styled-content style=\"fixed-case\">YB<\/jats:styled-content>, 1023.03\u00a0\u00b1\u00a04.0 and 1286.17\u00a0\u00b1\u00a04.4\u00a0\u03bcg\u00a0mL<jats:sup>\u22121<\/jats:sup> for <jats:styled-content style=\"fixed-case\">TA<\/jats:styled-content> and 89.12\u00a0\u00b1\u00a02.3 and 111.58\u00a0\u00b1\u00a03.5\u00a0\u03bcg\u00a0mL<jats:sup>\u22121<\/jats:sup> for <jats:styled-content style=\"fixed-case\">YBTA<\/jats:styled-content>, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The present study revealed the inhibitory effect of <jats:styled-content style=\"fixed-case\">YB<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> TA<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">YBTA<\/jats:styled-content> on <jats:italic><jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>.\u00a0acne<\/jats:italic> growth and inflammation. Clinical studies have suggested the anti\u2010acne benefits of formulations containing <jats:styled-content style=\"fixed-case\">YB<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">TA<\/jats:styled-content>. The findings obtained from the present <jats:italic>in vitro<\/jats:italic> studies provide evidence to support the mechanism of anti\u2010acne properties of <jats:styled-content style=\"fixed-case\">YB<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">TA<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ics.12134","type":"journal-article","created":{"date-parts":[[2014,4,19]],"date-time":"2014-04-19T11:12:25Z","timestamp":1397905945000},"page":"361-368","source":"Crossref","is-referenced-by-count":17,"title":["Yashada bhasma (<scp>Z<\/scp>inc calx) and <scp>T<\/scp>ankana (<scp>B<\/scp>orax) inhibit <i><scp>P<\/scp>ropionibacterium acne<\/i> and suppresses acne induced inflammation <i>in vitro<\/i>"],"prefix":"10.1111","volume":"36","author":[{"given":"R.","family":"Sandeep Varma","sequence":"first","affiliation":[{"name":"Department of Cell Biology Research and Development The Himalaya Drug Company Bangalore 562 162 India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Shamsia","sequence":"additional","affiliation":[{"name":"Department of Microbiology Research and Development The Himalaya Drug Company Bangalore 562 162 India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. S.","family":"Thiyagarajan","sequence":"additional","affiliation":[{"name":"Department of Cell Biology Research and Development The Himalaya Drug Company Bangalore 562 162 India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vidyashankar","sequence":"additional","affiliation":[{"name":"Department of Cell Biology Research and Development The Himalaya Drug Company Bangalore 562 162 India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. S.","family":"Patki","sequence":"additional","affiliation":[{"name":"Medical Services and Clinical Trials Research and Development The Himalaya Drug Company Bangalore 562 162 India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,5,5]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1159\/000087011"},{"key":"e_1_2_7_3_1","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1128\/iai.63.8.3158-3165.1995","article-title":"Induction of pro\u2010inflammatory cytokines by a soluble factor of Propionibacterium acnes. Implication for chronic inflammatory acne","volume":"63","author":"Vowels B.R.","year":"1995","journal-title":"Infect. Immun."},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(02)00013-0"},{"key":"e_1_2_7_5_1","first-page":"117","article-title":"Antibody response to crude cell lysate of Propionibacterum acnes and induction of pro inflammatory cytokines in patients with acne and normal healthy subjects","volume":"42","author":"Basal E.","year":"2004","journal-title":"J. Microbiol."},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2004.05762.x"},{"key":"e_1_2_7_7_1","first-page":"789","article-title":"Ayurveda and natural products drug discovery","volume":"86","author":"Patwardhan B.","year":"2004","journal-title":"Curr. Sci."},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/bip.20947"},{"key":"e_1_2_7_9_1","first-page":"165","article-title":"X\u2010Ray diffraction analysis of Yashada bhasma: an ayurvedic metallic preparation","volume":"3","author":"Santosh B.","year":"2012","journal-title":"Int. J. Res. Ayur. Pharm."},{"key":"e_1_2_7_10_1","first-page":"1","article-title":"Analytical studies of Yashada bhasma (zinc based ayurvedic metallic preparation) with reference to ancient and modern parameters","volume":"1","author":"Santosh B.","year":"2013","journal-title":"Int. Ayur. Med. J."},{"key":"e_1_2_7_11_1","first-page":"541","article-title":"Low doses of Zinc gluconate for inflammatory acne","volume":"69","author":"Dreno B.","year":"1989","journal-title":"Acta Derm. Venereol."},{"key":"e_1_2_7_12_1","first-page":"549","article-title":"Erythromycin resistance of cutaneous bacterial flora in acne","volume":"11","author":"Dreno B.","year":"2001","journal-title":"Eur. J. Dermatol."},{"key":"e_1_2_7_13_1","first-page":"4","article-title":"Pathophysiology of acne vulgaris: recent data, new understanding of the treatments","volume":"14","author":"Pawin H.","year":"2004","journal-title":"Eur. J. Dermatol."},{"key":"e_1_2_7_14_1","volume-title":"Indian Materia Medica","author":"Nadkarni K.M.","year":"2000"},{"key":"e_1_2_7_15_1","first-page":"18","article-title":"Physico\u2010chemical standardization of Tankana (borax): an ayurvedic mineral drug","volume":"1","author":"Srinivasulu B.","year":"2012","journal-title":"Pharma Innovation"},{"key":"e_1_2_7_16_1","first-page":"17","article-title":"In vitro anti inflammatory activity of Tankana Churna","volume":"40","author":"Kumar B.S.A.","year":"2013","journal-title":"Food Feed Res."},{"key":"e_1_2_7_17_1","first-page":"65","article-title":"Contribution of a 3% solution of boric acid in the treatment of deep wounds with loss of substance","volume":"36","author":"Borrelly J.","year":"1991","journal-title":"Ann. Chir. Plast. Esthet."},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.2527\/2001.7961549x"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2008.03.005"},{"key":"e_1_2_7_20_1","first-page":"138","article-title":"Treatment of acne vulgaris with new polyherbal formulations, Clarina cream and Purim tablets","volume":"46","author":"Kumar A.","year":"2001","journal-title":"Indian J. Dermatol."},{"key":"e_1_2_7_21_1","first-page":"27","article-title":"Evaluation of efficacy and safety of Clarina cream in newly diagnosed and previously treated cases of acne vulgaris","volume":"14","author":"Jerajani H.R.","year":"2004","journal-title":"Ind. J. Clin. Pract."},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2004.05.047"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.3109\/1547691X.2011.603389"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb02929.x"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(02)00013-0"},{"key":"e_1_2_7_26_1","first-page":"359","article-title":"Antibiotic resistance of Propionibacterium acnes in acne vulgaris","volume":"15","author":"Swanson J.K.","year":"2003","journal-title":"Dermatol. Nurs."},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2005.04.038"},{"key":"e_1_2_7_28_1","first-page":"901","article-title":"Ayurvedic bhasma: the most ancient application of nanomedicine","volume":"69","author":"Sarkar P.K.","year":"2010","journal-title":"J. Sci. Ind. Res."},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecam\/nep015"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11051-008-9414-z"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-8520.68195"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2012.05.045"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1978.03290200044019"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.2009.28836"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2000.00562.x"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2010.04815.x"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1992.tb15124.x"},{"key":"e_1_2_7_38_1","first-page":"152","article-title":"Effect of Zinc gluconate on Propionibacterum acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study","volume":"15","author":"Dreno B.","year":"2005","journal-title":"Eur. J. Dermatol."},{"key":"e_1_2_7_39_1","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1093\/jn\/133.12.4077","article-title":"Zinc oxide protects cultured enterocytes from the damage induced by Escherichia coli","volume":"133","author":"Rosselli M.","year":"2003","journal-title":"J. Nutr."},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-670X(1999)12:3<221::AID-JTRA6>3.0.CO;2-X"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:PHAM.0000041459.63362.6f"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.3923\/ijp.2006.374.381"}],"container-title":["International Journal of Cosmetic Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fics.12134","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ics.12134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T09:05:14Z","timestamp":1696237514000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ics.12134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,5]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.1111\/ics.12134"],"URL":"https:\/\/doi.org\/10.1111\/ics.12134","archive":["Portico"],"relation":{},"ISSN":["0142-5463","1468-2494"],"issn-type":[{"value":"0142-5463","type":"print"},{"value":"1468-2494","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,5]]}}}